Avesthagen Wipro have launched genetic tests for cancer, neurological disorders, and rare diseases

Avesthagen is an India-based globally-focused biotechnology company with a corporate mission to utilize innovative science to develop new products and novel technologies for predictive, preventive, and personalized healthcare and food security through the convergence of food, pharmaceuticals, and population genetics.

Avesthagen Limited, a global leader in information technology, consulting, and business process outsourcing, has formed a four-year strategic partnership with Wipro Limited to commercialize its genetic testing portfolio. The genome panels in the portfolio provide highly specific, disease-centric analysis for cancer, neurodegenerative diseases, autoimmune disorders, and rare disease conditions.

Avesthagen and Wipro will collaborate on the project "Cancer Risk Assessed by NGS Profiling of Circulating free DNA and RNA for Lung Cancer Project Related Genomics Sequencing Services." The project will be co-led by Avesthagen and Wipro, with Wipro's cutting-edge Lifesciences lab performing initial sample processing, generating data on the latest Next-generation sequencing platforms, compiling genomic sequences, and analyzing detailed molecular information using computational AI/ML tools.

Wipro's expertise in genomics and biomarker discovery will assist Avesthagen in developing well-regulated workflows during the development of CALiBRx® gene panels.  The tests would primarily be available in oncology-focused super specialty clinics and hospitals. Later, it will strategically release diagnostic tools for upper respiratory cancers such as head, neck, and esophageal cancers. The project would result in a new generation of genome-led medicine in the medium and long term.

"Genomics-based innovation is in Avesthagen's DNA." The Avestagenome Project, which began in 2008, is the world's largest epidemiological study of a consanguineous population.  "The diagnostic tools portfolio that we are launching today is the result of the collective knowledge that we have amassed since, and we are excited to work with WIPRO to bring clinical genetics-based precision diagnostics to the people," says Dr. Villoo Morawala-Patell, Founder, Chairman, and Managing Director, Avesthagen Limited. 

The 624 gene panel CALiBRxO will be available in the market in Q3 2022 and will be used to treat cancers and neurological conditions. It presents a targeted screening approach of 624 genes implicated in oncological conditions. 

Tags : #avesthagen #wipro #Genetic #Cancer #neurological #rarediseases #featured #healthcare #medicircle #smitakumar

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

India Joins International Medical Device Regulators Forum: A Leap Toward Global Health CollaborationOctober 05, 2024
The Science of Overeating: Why You Can’t Stop at Just One BiteOctober 05, 2024
The Toxic Truth: How Alcohol Fuels Six Deadly CancersOctober 05, 2024
Lenacapavir: India’s Pharmaceutical Giants to Produce a Twice-a-Year Pill Poised to Rewrite HIV PreventionOctober 04, 2024
Can Ending Smoking by 2050 Really Save 1.2 Million Lives? New Lancet Study RevealsOctober 04, 2024
Colon Cancer Crisis: Why It’s Attacking Younger GenerationsOctober 04, 2024
Eye Health Program for Low-Income Residents Launched in Hingoli, MaharashtraOctober 04, 2024
Are we on the path to end AIDS by 2030?October 03, 2024
TTK Prestige Announces Shubhutsav- A Special Festive Offer, Elevating Home CookingOctober 03, 2024
Tata Soulfull Launches Tata Soulfull Corn Flakes+, With the Goodness of Millets in Every Flake October 03, 2024
The Bitter Truth Behind Sweet Treats: Hidden Cancer Risks in Your Favorite CakesOctober 03, 2024
Ageing Faster Than You Think? Discover How a Simple Cheek Swab Could Save Your LifeOctober 03, 2024
The University of Tasmania invites international student applications for their Tasmanian International ScholarshipOctober 03, 2024
A New Hope for Type 1 Diabetes: Tackling Blood Sugar Drops with Somatostatin BlockersOctober 03, 2024
Prostate Cancer Strikes Young: The Alarming Rise of Aggressive Cases in Men Under 50October 03, 2024
Fleetguard Filters Private Limited (FFPL) Wins Prestigious ‘Iconic Brands of India 2024’ at the This recognition adds to Fleetguard's growing list of accolades, further establishing its position as a leader in the automotive industry. The company remains dedicated to advancing innovation and providing solutions that consistently meet the changing needs of its customers.October 03, 2024
Marico’s Saffola Honey and Pankaj Tripathi Uncover the Secret of Shuddha Honey in its latest TVCOctober 01, 2024
Mr. Piush Srivastava, Head of Marketing and Corporate Communications of Fleetguard Filters Pvt. Ltd, Awarded 'Marketing Maverick' by Dun & Bradstreet October 01, 2024
Chikungunya Strikes Back: The Forgotten Virus Making a Deadly ComebackOctober 01, 2024
The Hidden Cancer Risk in Your Morning Routine: How Poor Oral Hygiene May Be Endangering Your HealthOctober 01, 2024